A novel variant in the LIPA gene associated with distinct phenotype

1Ameis D, Merkel M, Eckerskorn C, Greten H. Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase. Eur J Biochem. 1994; 219(3): 905-14.Ameis D Merkel M Eckerskorn C Greten H Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase Eur J Biochem 1994 2193 905 1410.1111/j.1432-1033.1994.tb18572.x8112342Search in Google Scholar

2Bernstein DL, Hülkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013; 58(6): 1230-43.Bernstein DL Hülkova H Bialer MG Desnick RJ Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease J Hepatol 2013 586 1230 4310.1016/j.jhep.2013.02.01423485521Search in Google Scholar

3Aslanidis C, Ries S, Fehringer P, Büchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics. 1996; 33(1) :85-93.Aslanidis C Ries S Fehringer P Büchler C Klima H Schmitz G Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity Genomics 1996 331 85 9310.1006/geno.1996.01628617513Search in Google Scholar

4Wilson DP, Patni N. Lysosomal Acid Lipase Deficiency. [Updated 2020 Jan 18]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395569/Wilson DP Patni N Lysosomal Acid Lipase Deficiency Updated 2020 Jan 18 In Feingold KR Anawalt B Boyce A et al., editors Endotext [Internet] South Dartmouth (MA) MDText.com Inc.; 2000-. Available from https://www.ncbi.nlm.nih.gov/books/NBK395569/Search in Google Scholar

5Scott SA, Liu B, Nazarenko I, Martis S, Kozlitina J, Yang Y et al. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology. 2013; 58(3): 958-65.Scott SA Liu B Nazarenko I Martis S Kozlitina J Yang Y et al Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups Hepatology 2013 583 958 6510.1002/hep.26327369014923424026Search in Google Scholar

6Cappuccio G, Donti TR, Hubert L, Sun Q, Elsea SH. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights. J Inherit Metab Dis. 2019; 42(3): 509-18.Cappuccio G Donti TR Hubert L Sun Q Elsea SH Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights J Inherit Metab Dis 2019 423 509 1810.1002/jimd.12057856486030684275Search in Google Scholar

7Pisciotta L, Tozzi G, Travaglini L, Taurisano R, Lucchi T, Indolfi G et al. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants. Atherosclerosis. 2017; 265: 124-32.Pisciotta L Tozzi G Travaglini L Taurisano R Lucchi T Indolfi G et al Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants Atherosclerosis 2017 265 124 3210.1016/j.atherosclerosis.2017.08.02128881270Search in Google Scholar

8Zimetti F, Favari E, Cagliero P, Adorni MP, Ronda N, Bonardi R et al. Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease. Atherosclerosis [Internet]. 2015; 242(2): 443-9.Zimetti F Favari E Cagliero P Adorni MP Ronda N Bonardi R et al Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease Atherosclerosis [Internet] 2015 2422 443 910.1016/j.atherosclerosis.2015.08.00726291497Search in Google Scholar

9Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017; 2(9): 670-9.Pericleous M Kelly C Wang T Livingstone C Ala A Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency Lancet Gastroenterol Hepatol 2017 29 670 910.1016/S2468-1253(17)30052-328786388Search in Google Scholar

10Hůlková H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopathology. 2012; 60(7): 1107-13.Hůlková H Elleder M Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens Histopathology 2012 607 1107 1310.1111/j.1365-2559.2011.04164.x22621222Search in Google Scholar

11Thompson RJ, Portmann BC, Roberts EA. Genetic and metabolic liver disease. In: Burt AD, Portmann BC, Ferrell LD, editors. MacSween’s pathology of the liver (6th edition). Edinburgh: Churchil Livingstone Elsevier, 2012: 157-259 Thompson RJ Portmann BC Roberts EA Genetic and metabolic liver disease In Burt AD Portmann BC Ferrell LD editors MacSween’s pathology of the liver (6th edition) Edinburgh Churchil Livingstone Elsevier 2012 15725910.1016/B978-0-7020-3398-8.00004-0Search in Google Scholar

12vom Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau C, Vogt C, van Weely S, Aerts J, Müller G, Häussinger D. Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. J Hepatol. 1999; 31(4): 741-6.vom Dahl S Harzer K Rolfs A Albrecht B Niederau C Vogt C van Weely S Aerts J Müller G Häussinger D Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation J Hepatol 1999 314 741 610.1016/S0168-8278(99)80356-010551400Search in Google Scholar

13Boenzi S, Deodato F, Taurisano R, Goffredo BM, Rizzo C, Dionisi-Vici C. Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism. J Lipid Res. 2016; 57(3): 361-7.Boenzi S Deodato F Taurisano R Goffredo BM Rizzo C Dionisi-Vici C Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism J Lipid Res 2016 573 361 710.1194/jlr.M061978476698526733147Search in Google Scholar

14Su K, Donaldson E, Sharma R. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa. Appl Clin Genet. 2016; 9: 157-67.Su K Donaldson E Sharma R Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa Appl Clin Genet 2016 9 157 6710.2147/TACG.S86760507473527799810Search in Google Scholar

15Pastores GM, Hughes DA. Lysosomal Acid Lipase Deficiency: Therapeutic Options. Drug Des Devel Ther. 2020; 14: 591-601.Pastores GM Hughes DA Lysosomal Acid Lipase Deficiency: Therapeutic Options Drug Des Devel Ther 2020 14 591 60110.2147/DDDT.S149264702387932103901Search in Google Scholar

16Carter A, Brackley SM, Gao J, Mann JP. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD. J Hepatol. 2019; 70(1): 142-50.Carter A Brackley SM Gao J Mann JP The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD J Hepatol 2019 701 142 5010.1016/j.jhep.2018.09.02830315827Search in Google Scholar

17Del Angel G, Hutchinson AT, Jain NK, Forbes CD, Reynders J. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency. Hum Mutat. 2019; 40(11): 2007-20.Del Angel G Hutchinson AT Jain NK Forbes CD Reynders J Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency Hum Mutat 2019 4011 2007 2010.1002/humu.23837685216331180157Search in Google Scholar

18Zhang B, Porto AF. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2013; 56(6): 682-5.Zhang B Porto AF Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency J Pediatr Gastroenterol Nutr 2013 566 682 510.1097/MPG.0b013e31828b36ac23403440Search in Google Scholar

19Ruiz-Andrés C, Sellés E, Arias A, Gort L; Spanish LAL Deficiency Working Group. Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease. JIMD Rep. 2017; 37: 7-12.Ruiz-Andrés C Sellés E Arias A Gort L Spanish LAL Deficiency Working Group. Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease JIMD Rep 2017 37 7 1210.1007/8904_2017_6574005328220406Search in Google Scholar

20Hoffman EP, Barr ML, Giovanni MA, Murray MF. Lysosomal Acid Lipase Deficiency. 2015 Jul 30 [Updated 2016 Sep 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305870/Hoffman EP Barr ML Giovanni MA Murray MF Lysosomal Acid Lipase Deficiency. 2015 Jul 30 [Updated 2016 Sep 1] In Adam MP Ardinger HH Pagon RA et al., editors GeneReviews® [Internet] Seattle (WA) University of Washington, Seattle 1993-2021 Available from https://www.ncbi.nlm.nih.gov/books/NBK305870/Search in Google Scholar

21Pullinger CR, Stock EO, Movsesyan I, Malloy MJ, Frost PH, Tripuraneni R et al. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency. J Clin Lipidol. 2015; 9(5): 716-26.e1. Pullinger CR Stock EO Movsesyan I Malloy MJ Frost PH Tripuraneni R et al Identification and metabolic profiling of patients with lysosomal acid lipase deficiency J Clin Lipidol 2015 95 716 26e110.1016/j.jacl.2015.07.00826350820Search in Google Scholar

22Aerts JM, Hollak CE, van Breemen M, Maas M, Groener JE, Boot RG. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Acta Paediatr Suppl. 2005; 94(447): 43-6; discussion 37-8. Aerts JM Hollak CE van Breemen M Maas M Groener JE Boot RG Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases Acta Paediatr Suppl 2005 94447 43 6 discussion 37-810.1080/08035320510028094Search in Google Scholar

23Zlatkovic M, Stankovic I, Prokic D, Plamenac P. Patohistoloska dijagnostika bolesti nagomilavanja estra holesterola [Histopathologic diagnosis of cholesterol ester storage disease]. Srp Arh Celok Lek. 2001; 129(7-8): 207-10Zlatkovic M Stankovic I Prokic D Plamenac P Patohistoloska dijagnostika bolesti nagomilavanja estra holesterola [Histopathologic diagnosis of cholesterol ester storage disease] Srp Arh Celok Lek 2001 1297-8 207 10Search in Google Scholar

24Fasano T, Pisciotta L, Bocchi L, Guardamagna O, Assandro P, Rabacchi C et al. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab. 2012; 105(3): 450-6.Fasano T Pisciotta L Bocchi L Guardamagna O Assandro P Rabacchi C et al Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease Mol Genet Metab 2012 1053 450 610.1016/j.ymgme.2011.12.00822227072Search in Google Scholar

25Arterburn JN, Lee WM, Wood RP, Shaw BW, Markin RS. Orthotopic liver transplantation for cholesteryl ester storage disease. J Clin Gastroenterol. 1991; 13(4): 482-5.Arterburn JN Lee WM Wood RP Shaw BW Markin RS Orthotopic liver transplantation for cholesteryl ester storage disease J Clin Gastroenterol 1991 134 482 510.1097/00004836-199108000-000281918862Search in Google Scholar

26Andrade J, Waters PJ, Singh RS, Levin A, Toh BC, Vallance HD et al. Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test. Clin J Am Soc Nephrol. 2008; 3(1): 139-45.Andrade J Waters PJ Singh RS Levin A Toh BC Vallance HD et al Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test Clin J Am Soc Nephrol 2008 31 139 4510.2215/CJN.02490607239097718003767Search in Google Scholar

27Verma J, Thomas DC, Kasper DC, Sharma S, Puri RD, Bijarnia-Mahay S et al. Inherited Metabolic Disorders: Efficacy of Enzyme Assays on Dried Blood Spots for the Diagnosis of Lysosomal Storage Disorders. JIMD Rep. 2017; 31: 15-27.Verma J Thomas DC Kasper DC Sharma S Puri RD Bijarnia-Mahay S et al Inherited Metabolic Disorders: Efficacy of Enzyme Assays on Dried Blood Spots for the Diagnosis of Lysosomal Storage Disorders JIMD Rep 2017 31 15 2710.1007/8904_2016_548538864527008195Search in Google Scholar

28Masi S, Chennamaneni N, Turecek F, Scott CR, Gelb MH. Specific Substrate for the Assay of Lysosomal Acid Lipase. Clin Chem. 2018; 64(4): 690-6.Masi S Chennamaneni N Turecek F Scott CR Gelb MH Specific Substrate for the Assay of Lysosomal Acid Lipase Clin Chem 2018 644 690 610.1373/clinchem.2017.282251638365229339442Search in Google Scholar

29Lukacs Z, Barr M, Hamilton J. Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chim Acta. 2017;471:201-5.Lukacs Z Barr M Hamilton J Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2 Clin Chim Acta 2017471201 510.1016/j.cca.2017.05.02728532785Search in Google Scholar

30Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-Prieto M, García-Honrubia A, Pérez I et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007; 50(25): 2399-403.Monserrat L Gimeno-Blanes JR Marín F Hermida-Prieto M García-Honrubia A Pérez I et al Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy J Am Coll Cardiol 2007 5025 2399 40310.1016/j.jacc.2007.06.06218154965Search in Google Scholar

31Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F, Marulkar S et al. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet J Rare Dis. 2021; 16(1): 13.Vijay S Brassier A Ghosh A Fecarotta S Abel F Marulkar S et al Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies Orphanet J Rare Dis 2021 161 1310.1186/s13023-020-01577-4778969133407676Search in Google Scholar

32Mashima R, Okuyama T, Ohira M. Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry. Int J Mol Sci. 2020; 21(8): 2704.Mashima R Okuyama T Ohira M Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry Int J Mol Sci 2020 218 270410.3390/ijms21082704721588732295281Search in Google Scholar

33Clark WT, Yu GK, Aoyagi-Scharber M, LeBowitz JH. Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence. PLoS One. 2018; 13(7): e0200008.Clark WT Yu GK Aoyagi-Scharber M LeBowitz JH Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence PLoS One 2018 137 e020000810.1371/journal.pone.0200008603480929979746Search in Google Scholar

34Reiner Ž, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S et al. Lysosomal acid lipase deficiency-an under-recognized cause of dyslipidemia and liver dysfunction. Atherosclerosis. 2014; 235(1): 21-30.Reiner Ž Guardamagna O Nair D Soran H Hovingh K Bertolini S et al Lysosomal acid lipase deficiency-an under-recognized cause of dyslipidemia and liver dysfunction Atherosclerosis 2014 2351 21 3010.1016/j.atherosclerosis.2014.04.00324792990Search in Google Scholar

35Guénard F, Houde A, Bouchard L, Tchernof A, Deshaies Y, Biron S et al. Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients. Obesity (Silver Spring). 2012; 20(10): 2075-82.Guénard F Houde A Bouchard L Tchernof A Deshaies Y Biron S et al Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients Obesity (Silver Spring) 2012 2010 2075 8210.1038/oby.2012.5222395809Search in Google Scholar

36Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017; 136(6): 665-77.Stenson PD Mort M Ball EV Evans K Hayden M Heywood S et al The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies Hum Genet 2017 1366 665 7710.1007/s00439-017-1779-6542936028349240Search in Google Scholar

37Vinje T, Laerdahl JK, Bjune K, Leren TP, Strøm TB. Characterization of the mechanisms by which missense mutations in the lysosomal acid lipase gene disrupt enzymatic activity. Hum Mol Genet. 2019; 28(18): 3043-52.Vinje T Laerdahl JK Bjune K Leren TP Strøm TB Characterization of the mechanisms by which missense mutations in the lysosomal acid lipase gene disrupt enzymatic activity Hum Mol Genet 2019 2818 3043 5210.1093/hmg/ddz11431131398Search in Google Scholar

38Oetjen S, Kuhl D, Hermey G. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis. J Neurochem. 2016; 139(3): 456-70.Oetjen S Kuhl D Hermey G Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis J Neurochem 2016 1393 456 7010.1111/jnc.1374427453211Search in Google Scholar

39Björses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Ellonen P et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet. 2000; 66(2): 378-92.Björses P Halonen M Palvimo JJ Kolmer M Aaltonen J Ellonen P et al Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein Am J Hum Genet 2000 662 378 9210.1086/302765128809010677297Search in Google Scholar